<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 12-year-old patient with <z:e sem="disease" ids="C0043194" disease_type="Disease or Syndrome" abbrv="">Wiskott-Aldrich syndrome</z:e> (WAS) was referred because of recurrent <z:hpo ids='HP_0002027'>abdominal pain</z:hpo> and bloody stools </plain></SENT>
<SENT sid="1" pm="."><plain>Ileocolic invagination was diagnosed and resection of the terminal ileum was performed </plain></SENT>
<SENT sid="2" pm="."><plain>Pathologic examination identified submucosal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> as the leading point of <z:hpo ids='HP_0002576'>intussusception</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Immunohistochemistry confirmed the diagnosis of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The use of chemotherapy with anti-CD20 monoclonal antibody led to complete clinical remission of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) accounts for more than 60% of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in children with primary <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo>, and it is the most common type of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> observed in WAS </plain></SENT>
<SENT sid="6" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> represents 40% to 50% of <z:hpo ids='HP_0000001'>all</z:hpo> NHL cases in childhood, but in WAS it has rarely been reported </plain></SENT>
<SENT sid="7" pm="."><plain>Mutation analysis of the WASP gene in this patient revealed missense mutation (105 C &gt; T) in exon 1 </plain></SENT>
<SENT sid="8" pm="."><plain>WAS protein (WASP) of <z:mpath ids='MPATH_458'>normal</z:mpath> size was present at a reduced amount in peripheral blood lymphocytes </plain></SENT>
<SENT sid="9" pm="."><plain>Complete lack of expression of WASP carries a greater risk for severe <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, <z:mp ids='MP_0001914'>bleeding</z:mp>, or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> development in WAS </plain></SENT>
<SENT sid="10" pm="."><plain>However, rare patients with residual expression of mutated WASP, like this patient, still may develop <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>